TSH Biopharm Corporation Limited (8432.TWO) — Stock Score Summary

TSH Biopharm Corporation Limited (8432.TWO) has a MoatMap StockRank of 100/100 based on Quality (81/100), Value (76/100), and Momentum (49/100) factor scores. The current signal is STRONG BUY.

Key Financial Metrics

Price$1.60
Market Cap$62M
P/E (TTM)13.90
Price/Book1.32
Return on Equity11.4%
Return on Invested Capital13.7%
Debt/Equity0.98
Gross Margin51.4%
Operating Margin18.5%
Revenue Growth-0.5%
Dividend Yield4.1%
Free Cash Flow$227K

TSH Biopharm Corporation Limited operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (Taiwan).

Frequently Asked Questions

What is TSH Biopharm Corporation Limited’s (8432.TWO) StockRank?
MoatMap’s StockRank for TSH Biopharm Corporation Limited (8432.TWO) is 100/100, with a Strong Buy signal. It is a composite of Quality (81), Value (76), and Momentum (49) factor ranks across MoatMap’s 19,000+ stock universe.
Does TSH Biopharm Corporation Limited have an economic moat?
TSH Biopharm Corporation Limited (8432.TWO) has a Quality factor score of 81/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is TSH Biopharm Corporation Limited a buy, hold, or sell?
MoatMap’s current signal for TSH Biopharm Corporation Limited (8432.TWO) is Strong Buy, based on a StockRank of 100/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is TSH Biopharm Corporation Limited in?
TSH Biopharm Corporation Limited (8432.TWO) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (Taiwan).
Browse all ranked stocks8432.TWO deep dive reportAI ChampionsHow we score stocksSense-check another stock